Question 1

What is Ipsen?

Accepted Answer

Ipsen is a Company.

Question 2

How often does Ipsen appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Ipsen first tracked by Ergen?

Accepted Answer

First tracked on Apr 20, 2026.

Question 4

When was Ipsen last mentioned in news?

Accepted Answer

Last active on Jun 29, 2026.

Question 5

What is Ipsen's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Ipsen in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Ipsen?

Accepted Answer

Ipsen acquires Kartos Therapeutics (Apr 20, 2026, 7 articles).

Question 8

How did the "Ipsen acquires Kartos Therapeutics" event impact Ipsen?

Accepted Answer

Ipsen is acquiring Kartos Therapeutics, expanding its oncology pipeline with navtemadlin, a late-stage rare blood cancer asset. This acquisition is expected to contribute to Ipsen's core operating income from 2029.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.